Lung cancer is not an infectious disease, but a malignant tumor originated from bronchial mucosa or glands in lungs. Infusion of anti-inflammatory fluid for lung cancer patients does not have anti-tumor effect, and infusion of anti-inflammatory fluid is ineffective. However, when lung cancer patients are accompanied by infection, they can be treated with infusion for anti-inflammation in order to achieve the therapeutic effect of controlling infection. Since the immunity level of lung cancer patients often decreases in the process of diagnosis and treatment, the body of lung cancer patients is more easily infected, and at this time it is necessary to use suitable anti-inflammatory drugs for the treatment of patients in a targeted way. If the patients have no symptoms of infection, they do not need to receive anti-inflammatory fluids. At the same time, lung cancer patients need to keep a good mindset, actively cooperate with physicians in treatment, and should not use drugs without authorization, but should use drugs reasonably under the guidance of physicians.